Conference item : Abstract
CIELO: a randomized, double-blind, placebo-controlled, phase 3 basket study of satralizumab in patients with NMDAR- or LGI1-antibody encephalitis
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 35.1KB, Terms of use)
-
- Publisher copy:
- 10.1002/ana.26484
Authors
- Publisher:
- Wiley
- Journal:
- Annals of Neurology More from this journal
- Volume:
- 92
- Issue:
- S29
- Pages:
- S137-S138
- Publication date:
- 2022-10-14
- Event title:
- 147th Annual Meeting of the American Neurological Association (ANA 2022)
- Event location:
- Chicago, IL, USA
- Event website:
- https://education.myana.org/content/147th-annual-meeting-american-neurological-association-ana2022
- Event start date:
- 2022-10-22
- Event end date:
- 2022-10-25
- DOI:
- EISSN:
-
1531-8249
- ISSN:
-
0364-5134
- Language:
-
English
- Subtype:
-
Abstract
- Pubs id:
-
1303263
- Local pid:
-
pubs:1303263
- Deposit date:
-
2025-02-07
- ARK identifier:
Terms of use
- Copyright holder:
- American Neurological Association
- Copyright date:
- 2022
- Rights statement:
- © 2022 American Neurological Association.
- Notes:
- This is the accepted manuscript version of the abstract. The final version is available online from Wiley at https://dx.doi.org/10.1002/ana.26484
If you are the owner of this record, you can report an update to it here: Report update to this record